img

Global Major Histocompatibility Complex Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Major Histocompatibility Complex Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

The major histocompatibility complex (MHC) is a large locus on vertebrate DNA containing a set of closely linked polymorphic genes that code for cell surface proteins essential for the adaptive immune system.
Major Histocompatibility Complex report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Major Histocompatibility Complex market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medical Care and Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Major Histocompatibility Complex industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Major Histocompatibility Complex key companies include Miltenyi Biotec, Santa Cruz Biotechnology, Abbexa, ProImmune, Creative BioMart and Novus Biologicals, etc. Miltenyi Biotec, Santa Cruz Biotechnology, Abbexa are top 3 players and held % share in total in 2022.
Major Histocompatibility Complex can be divided into MHC Class I, MHC Class II and MHC Class III,, etc. MHC Class I is the mainstream product in the market, accounting for % share globally in 2022.
Major Histocompatibility Complex is widely used in various fields, such as Medical Care, Research and Other,, etc. Medical Care provides greatest supports to the Major Histocompatibility Complex industry development. In 2022, global % share of Major Histocompatibility Complex went into Medical Care filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Major Histocompatibility Complex market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Miltenyi Biotec
Santa Cruz Biotechnology
Abbexa
ProImmune
Creative BioMart
Novus Biologicals
Segment by Type
MHC Class I
MHC Class II
MHC Class III

Segment by Application


Medical Care
Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Major Histocompatibility Complex market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Major Histocompatibility Complex introduction, etc. Major Histocompatibility Complex Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Major Histocompatibility Complex market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Major Histocompatibility Complex
1.1 Major Histocompatibility Complex Market Overview
1.1.1 Major Histocompatibility Complex Product Scope
1.1.2 Major Histocompatibility Complex Market Status and Outlook
1.2 Global Major Histocompatibility Complex Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Major Histocompatibility Complex Market Size by Region (2024-2034)
1.4 Global Major Histocompatibility Complex Historic Market Size by Region (2024-2024)
1.5 Global Major Histocompatibility Complex Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Major Histocompatibility Complex Market Size (2024-2034)
1.6.1 North America Major Histocompatibility Complex Market Size (2024-2034)
1.6.2 Europe Major Histocompatibility Complex Market Size (2024-2034)
1.6.3 Asia-Pacific Major Histocompatibility Complex Market Size (2024-2034)
1.6.4 Latin America Major Histocompatibility Complex Market Size (2024-2034)
1.6.5 Middle East & Africa Major Histocompatibility Complex Market Size (2024-2034)
2 Major Histocompatibility Complex Market by Type
2.1 Introduction
2.1.1 MHC Class I
2.1.2 MHC Class II
2.1.3 MHC Class III
2.2 Global Major Histocompatibility Complex Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Major Histocompatibility Complex Historic Market Size by Type (2024-2024)
2.2.2 Global Major Histocompatibility Complex Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Major Histocompatibility Complex Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Major Histocompatibility Complex Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Major Histocompatibility Complex Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Major Histocompatibility Complex Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Major Histocompatibility Complex Revenue Breakdown by Type (2024-2034)
3 Major Histocompatibility Complex Market Overview by Application
3.1 Introduction
3.1.1 Medical Care
3.1.2 Research
3.1.3 Other
3.2 Global Major Histocompatibility Complex Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Major Histocompatibility Complex Historic Market Size by Application (2024-2024)
3.2.2 Global Major Histocompatibility Complex Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Major Histocompatibility Complex Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Major Histocompatibility Complex Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Major Histocompatibility Complex Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Major Histocompatibility Complex Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Major Histocompatibility Complex Revenue Breakdown by Application (2024-2034)
4 Major Histocompatibility Complex Competition Analysis by Players
4.1 Global Major Histocompatibility Complex Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Major Histocompatibility Complex as of 2022)
4.3 Date of Key Players Enter into Major Histocompatibility Complex Market
4.4 Global Top Players Major Histocompatibility Complex Headquarters and Area Served
4.5 Key Players Major Histocompatibility Complex Product Solution and Service
4.6 Competitive Status
4.6.1 Major Histocompatibility Complex Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Miltenyi Biotec
5.1.1 Miltenyi Biotec Profile
5.1.2 Miltenyi Biotec Main Business
5.1.3 Miltenyi Biotec Major Histocompatibility Complex Products, Services and Solutions
5.1.4 Miltenyi Biotec Major Histocompatibility Complex Revenue (US$ Million) & (2024-2024)
5.1.5 Miltenyi Biotec Recent Developments
5.2 Santa Cruz Biotechnology
5.2.1 Santa Cruz Biotechnology Profile
5.2.2 Santa Cruz Biotechnology Main Business
5.2.3 Santa Cruz Biotechnology Major Histocompatibility Complex Products, Services and Solutions
5.2.4 Santa Cruz Biotechnology Major Histocompatibility Complex Revenue (US$ Million) & (2024-2024)
5.2.5 Santa Cruz Biotechnology Recent Developments
5.3 Abbexa
5.3.1 Abbexa Profile
5.3.2 Abbexa Main Business
5.3.3 Abbexa Major Histocompatibility Complex Products, Services and Solutions
5.3.4 Abbexa Major Histocompatibility Complex Revenue (US$ Million) & (2024-2024)
5.3.5 ProImmune Recent Developments
5.4 ProImmune
5.4.1 ProImmune Profile
5.4.2 ProImmune Main Business
5.4.3 ProImmune Major Histocompatibility Complex Products, Services and Solutions
5.4.4 ProImmune Major Histocompatibility Complex Revenue (US$ Million) & (2024-2024)
5.4.5 ProImmune Recent Developments
5.5 Creative BioMart
5.5.1 Creative BioMart Profile
5.5.2 Creative BioMart Main Business
5.5.3 Creative BioMart Major Histocompatibility Complex Products, Services and Solutions
5.5.4 Creative BioMart Major Histocompatibility Complex Revenue (US$ Million) & (2024-2024)
5.5.5 Creative BioMart Recent Developments
5.6 Novus Biologicals
5.6.1 Novus Biologicals Profile
5.6.2 Novus Biologicals Main Business
5.6.3 Novus Biologicals Major Histocompatibility Complex Products, Services and Solutions
5.6.4 Novus Biologicals Major Histocompatibility Complex Revenue (US$ Million) & (2024-2024)
5.6.5 Novus Biologicals Recent Developments
6 North America
6.1 North America Major Histocompatibility Complex Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Major Histocompatibility Complex Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Major Histocompatibility Complex Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Major Histocompatibility Complex Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Major Histocompatibility Complex Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Major Histocompatibility Complex Market Dynamics
11.1 Major Histocompatibility Complex Industry Trends
11.2 Major Histocompatibility Complex Market Drivers
11.3 Major Histocompatibility Complex Market Challenges
11.4 Major Histocompatibility Complex Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Major Histocompatibility Complex Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Major Histocompatibility Complex Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Major Histocompatibility Complex Market Size Share by Region (2024-2024)
Table 4. Global Major Histocompatibility Complex Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Major Histocompatibility Complex Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Major Histocompatibility Complex Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Major Histocompatibility Complex Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Major Histocompatibility Complex Revenue Market Share by Type (2024-2024)
Table 9. Global Major Histocompatibility Complex Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Major Histocompatibility Complex Revenue Market Share by Type (2024-2034)
Table 11. North America Major Histocompatibility Complex Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Major Histocompatibility Complex Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Major Histocompatibility Complex Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Major Histocompatibility Complex Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Major Histocompatibility Complex Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Major Histocompatibility Complex Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Major Histocompatibility Complex Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Major Histocompatibility Complex Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Major Histocompatibility Complex Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Major Histocompatibility Complex Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Major Histocompatibility Complex Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Major Histocompatibility Complex Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Major Histocompatibility Complex Revenue Market Share by Application (2024-2024)
Table 24. Global Major Histocompatibility Complex Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Major Histocompatibility Complex Revenue Market Share by Application (2024-2034)
Table 26. North America Major Histocompatibility Complex Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Major Histocompatibility Complex Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Major Histocompatibility Complex Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Major Histocompatibility Complex Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Major Histocompatibility Complex Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Major Histocompatibility Complex Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Major Histocompatibility Complex Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Major Histocompatibility Complex Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Major Histocompatibility Complex Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Major Histocompatibility Complex Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Major Histocompatibility Complex Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Major Histocompatibility Complex Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Major Histocompatibility Complex as of 2022)
Table 39. Date of Key Players Enter into Major Histocompatibility Complex Market
Table 40. Global Major Histocompatibility Complex Key Players Headquarters and Area Served
Table 41. Major Histocompatibility Complex Product Solution and Service
Table 42. Global Major Histocompatibility Complex Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Miltenyi Biotec Basic Information List
Table 45. Miltenyi Biotec Description and Business Overview
Table 46. Miltenyi Biotec Major Histocompatibility Complex Products, Services and Solutions
Table 47. Revenue (US$ Million) in Major Histocompatibility Complex Business of Miltenyi Biotec (2024-2024)
Table 48. Miltenyi Biotec Recent Developments
Table 49. Santa Cruz Biotechnology Basic Information List
Table 50. Santa Cruz Biotechnology Description and Business Overview
Table 51. Santa Cruz Biotechnology Major Histocompatibility Complex Products, Services and Solutions
Table 52. Revenue (US$ Million) in Major Histocompatibility Complex Business of Santa Cruz Biotechnology (2024-2024)
Table 53. Santa Cruz Biotechnology Recent Developments
Table 54. Abbexa Basic Information List
Table 55. Abbexa Description and Business Overview
Table 56. Abbexa Major Histocompatibility Complex Products, Services and Solutions
Table 57. Revenue (US$ Million) in Major Histocompatibility Complex Business of Abbexa (2024-2024)
Table 58. Abbexa Recent Developments
Table 59. ProImmune Basic Information List
Table 60. ProImmune Description and Business Overview
Table 61. ProImmune Major Histocompatibility Complex Products, Services and Solutions
Table 62. Revenue (US$ Million) in Major Histocompatibility Complex Business of ProImmune (2024-2024)
Table 63. ProImmune Recent Developments
Table 64. Creative BioMart Basic Information List
Table 65. Creative BioMart Description and Business Overview
Table 66. Creative BioMart Major Histocompatibility Complex Products, Services and Solutions
Table 67. Revenue (US$ Million) in Major Histocompatibility Complex Business of Creative BioMart (2024-2024)
Table 68. Creative BioMart Recent Developments
Table 69. Novus Biologicals Basic Information List
Table 70. Novus Biologicals Description and Business Overview
Table 71. Novus Biologicals Major Histocompatibility Complex Products, Services and Solutions
Table 72. Revenue (US$ Million) in Major Histocompatibility Complex Business of Novus Biologicals (2024-2024)
Table 73. Novus Biologicals Recent Developments
Table 74. North America Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 75. North America Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 76. Europe Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 77. Europe Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 78. Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Asia-Pacific Major Histocompatibility Complex Market Size by Region (2024-2024) & (US$ Million)
Table 80. Asia-Pacific Major Histocompatibility Complex Market Size by Region (2024-2034) & (US$ Million)
Table 81. Asia-Pacific Major Histocompatibility Complex Market Share by Region (2024-2024)
Table 82. Asia-Pacific Major Histocompatibility Complex Market Share by Region (2024-2034)
Table 83. Latin America Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 84. Latin America Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 85. Latin America Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 86. Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 87. Middle East & Africa Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 88. Middle East & Africa Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 89. Major Histocompatibility Complex Market Trends
Table 90. Major Histocompatibility Complex Market Drivers
Table 91. Major Histocompatibility Complex Market Challenges
Table 92. Major Histocompatibility Complex Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Major Histocompatibility Complex Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Major Histocompatibility Complex Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Major Histocompatibility Complex Market Share by Regions: 2022 VS 2034
Figure 4. Global Major Histocompatibility Complex Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Major Histocompatibility Complex Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Major Histocompatibility Complex Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Major Histocompatibility Complex Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of MHC Class I
Figure 11. Global MHC Class I Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of MHC Class II
Figure 13. Global MHC Class II Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of MHC Class III
Figure 15. Global MHC Class III Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Major Histocompatibility Complex Market Size Share by Type: 2022 & 2034
Figure 17. North America Major Histocompatibility Complex Revenue Market Share by Type (2024-2034)
Figure 18. Europe Major Histocompatibility Complex Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Major Histocompatibility Complex Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Major Histocompatibility Complex Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Major Histocompatibility Complex Revenue Market Share by Type (2024-2034)
Figure 22. Medical Care Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Research Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Major Histocompatibility Complex Market Size Share by Application: 2022 & 2034
Figure 26. North America Major Histocompatibility Complex Revenue Market Share by Application (2024-2034)
Figure 27. Europe Major Histocompatibility Complex Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Major Histocompatibility Complex Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Major Histocompatibility Complex Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Major Histocompatibility Complex Revenue Market Share by Application (2024-2034)
Figure 31. Major Histocompatibility Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Major Histocompatibility Complex Market Share in 2022
Figure 33. North America Major Histocompatibility Complex Market Share by Country (2024-2034)
Figure 34. United States Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 37. France Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Major Histocompatibility Complex Market Share by Region (2024-2034)
Figure 43. China Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 47. India Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Major Histocompatibility Complex Market Share by Country (2024-2034)
Figure 50. Mexico Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Major Histocompatibility Complex Market Share by Country (2024-2034)
Figure 53. Turkey Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Major Histocompatibility Complex Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report